HOUSTON, Oct. 11, 2004 (PRIMEZONE) -- Gulf Biomedical Corporation (Pink Sheets:GBIC), a sixteen-year-old Houston-based laser research and manufacturing firm, announced today that it has completed the acquisition from David Beard/Traderite, LLC of the product line "Special Care, Health and Hair." The purchase included all assets, liabilities, copyrights, patent rights and inventories related to the hair-growing supplement and associated product developed by David Beard/Traderite, LLC.
"Special Care, Health and Hair" is a vitamin supplement developed by Beard in 2002 after a series of formulated chemical studies on human subjects conducted with pharmaceutical grade components. In late January 2003, the dosage was standardized as a two-tablet formula intended to stimulate hair growth and repair from common hair loss maladies such as Andogenetic Alopecia (AGA), Alopecia Areata, Congenital Atrichia and Trichotillomanis.
Gulf Biomedical Corporation will commence double-blind medical trials immediately. Goal of the trials: patent and copyright on the vitamin formulations.
The Private Securities Reform Act of 1995 provides a "Safe Harbor" for forward-looking statements. Certain information on this report contains statements that are forward-looking, such as plans for future expansion and anticipated sales growth. Certain forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future, and accordingly, such results may differ from those expressed or made by Gulf Biomedical Corporation. These risks and uncertainties include but are not limited to: development and expansion activities, dependence on existing management, financing activities, changes in state and federal laws and market competition factors. The information in this report is not intended to be and shall not constitute an offer to sell or a solicitation of an offer to buy a security. It is intended for information only.